The exact role of different types of dietary fat and the best approach to prevention in cardiovascular disease has been ...

There is broad consensus that the overall body of evidence shows lowering LDL (low-density lipoprotein) cholesterol provides ...

Nonprescription rosuvastatin pans out in a second trialThe TACTiC study included 1,196 participants (median age 63, 39.6% women) who completed the web app assessment and got the OK to use statins ...

The Ezetimibe Add-on to Statin for Effectiveness (EASE) trial included a total of 3030 patients on a stable dose of a statin but not yet at their NCEP ATP III LDL-cholesterol goal. [2] ...

Medscape interviewed Peter Sever, Co-Chair of ASCOT, about putting to rest the idea that reducing C-reactive protein with a statin has any cardiovascular benefits beyond lowering LDL cholesterol.

Concomitant use of statins improved survival among people with cancer treated with immune checkpoint inhibitors, according to results of a meta-analysis. “These findings highlight the potential ...

Among the 3,157 patients aged 80 years and older, compared with those who had a statin prescription of less than 2 years or none at all, those who had a statin prescription for 2 years had lower ...

Identifying the efficacy of combination therapy for LDL-C reduction in patients at very high risk of atherosclerotic cardiovascular disease - Moderate-intensity statin with ezetimibe combination ...

Based on robust randomized trial data and meta-analyses, FAU experts conclude that statins – particularly rosuvastatin and ...